About 5 results found for searched term "FA-Ala-Arg" (0.126 seconds)
| Cat.No. | Name | Target |
|---|---|---|
| M10558 | Recombinant human VEGF-C (HEK 293) | Cytokines and Growth Factors |
| Vascular endothelial growth factor C; VEGF-C (Ala112-Arg227) | ||
| Recombinant human VEGF-C (rhVEGF-C) is a member of the platelet-derived growth factor/vascular endothelial growth factor (PDGF/VEGF) family, is active in angiogenesis, lymphangiogenesis and endothelial cell growth and survival, and can also affect the permeability of blood vessels. | ||
| M42386 | FA-Ala-Arg | Metabolite/Endogenous Metabolite |
| FA-Ala-Arg is a dipeptide with furylacryloyl group. | ||
| M8855 | WR99210 | Others |
| WR99210 is a potent inhibitor of Plasmodium falciparum dihydrofolate reductase (DHFR), which is a major malarial drug target. | ||
| M15047 | Recombinant Mouse OSM (HEK 293) | Cytokines and Growth Factors |
| OncoM; oncostatin M | ||
| Protein Construction：OSM (Ala24-Arg206) Oncostatin M (OSM) is a multifunctional cytokine belonging to the interleukin-6 (IL-6) subfamily, which also includes IL-11, leukemia suppressor (LIF), ciliary nerve promoter, cardiac trophic factor-1 and novel nerve promoter factor-1. Protein structure: OSM (ALA24-ARG206), Accession # : P53347. | ||
| M28063 | Famitinib malate | VEGFR/PDGFR |
| SHR1020 malate | ||
| Famitinib (SHR1020) malate, an orally active multi-targeted kinase inhibitor, inhibits the activity of c-kit, VEGFR-2 and PDGFRβ with IC50 values of 2.3 nM, 4.7 nM and 6.6 nM, respectively. Famitinib malate induces cell apoptosis. Famitinib malate exerts powerful antitumor activity in human gastric cancer cells and xenografts, it can be used for the research of cancer. | ||
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.
